Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients

Metzner, Karin J.; Scherrer, Alexandra U.; von Wyl, Viktor; More

AIDS . 28(15):2231-2239, September 24, 2014.

Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy

Du Pasquier, Renaud A.; Jilek, Samantha; Kalubi, Malela; More

AIDS . 27(2):203-210, January 14, 2013.

Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir

Gutmann, Christine; Cusini, Alexia; Günthard, Huldrych F; More

AIDS . 24(15):2347-2354, September 24, 2010.

HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men

Rieder, Philip; Joos, Beda; von Wyl, Viktor; More

AIDS . 24(8):1177-1183, May 15, 2010.

The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection

Yerly, Sabine; Junier, Thomas; Gayet-Ageron, Angèle; More

AIDS . 23(11):1415-1423, July 17, 2009.

African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study

Müller, Viktor; von Wyl, Viktor; Yerly, Sabine; More

AIDS . 23(10):1269-1276, June 19, 2009.

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study

Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; More

AIDS . 21(16):2201-2207, October 2007.

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey

Yerly, Sabine; von Wyl, Viktor; Ledergerber, Bruno; More

AIDS . 21(16):2223-2229, October 2007.

Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients

Vora, Samir; Marcelin, Anne-Geneviève; Günthard, Huldrych F; More

AIDS . 20(1):35-40, January 2, 2006.

HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen

Martinez, Valérie; Marcelin, Anne-Geneviève; Morini, Jean-Pierre; More

AIDS . 19(10):1065-1069, July 1, 2005.

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy

Bart, Pierre-Alexandre; Rizzardi, G. Paolo; Tambussi, Giuseppe; More

AIDS . 14(13):1887-1897, September 8, 2000.

Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients

Bart, Pierre-Alexandre; Meuwly, Jean-Yves; Corpataux, Jean-Marc; More

AIDS . 13(12):1503-1509, August 20, 1999.

A placebo‐controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection

Rutschmann, Olivier T.; Opravil, Milos; Iten, Anne; More

AIDS . 12(8):F71-77, May 28, 1998.

A randomized double‐blind controlled study of 6 months of oral nutritional supplementation with arginine and Ω‐3 fatty acids in HIV‐infected patients

Pichard, Claude; Sudre, Philippe; Karsegard, Véronique; More

AIDS . 12(1):53-63, January 1, 1998.

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir

Lorenzi, Patrizio; Yerly, Sabine; Abderrakim, Karmine; More

AIDS . 11(12):F95-F99, October 11, 1997.